CTT Pharmaceutical Holdings, Inc. (CTTH)
OTCMKTS · Delayed Price · Currency is USD
0.0610
-0.0050 (-7.58%)
Jul 27, 2026, 12:41 PM EST
CTTH Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2014 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '14 Dec 31, 2014 | Feb '14 Feb 28, 2014 |
Cash & Equivalents | 0.01 | 0.02 | 0 | - | 0.08 | 0 |
Cash & Short-Term Investments | 0.01 | 0.02 | 0 | - | 0.08 | 0 |
Cash Growth | - | 13372.81% | - | - | 20399.75% | - |
Other Receivables | - | - | - | - | 0.01 | - |
Receivables | - | - | - | - | 0.01 | - |
Prepaid Expenses | - | - | - | - | 0.96 | - |
Total Current Assets | 0.01 | 0.02 | 0 | - | 1.05 | 0 |
Other Intangible Assets | 0.07 | 0.07 | 0.07 | 0.08 | - | - |
Long-Term Deferred Charges | - | 0 | - | - | - | - |
Other Long-Term Assets | - | - | - | - | 0.61 | - |
Total Assets | 0.08 | 0.09 | 0.07 | 0.08 | 1.66 | 0 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2014 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '14 Dec 31, 2014 | Feb '14 Feb 28, 2014 |
Accounts Payable | - | - | - | 0.01 | 0.02 | 0.01 |
Accrued Expenses | - | - | - | - | 0.06 | - |
Short-Term Debt | 0.02 | 0.02 | 0.02 | - | 0.09 | 0.02 |
Other Current Liabilities | 0.02 | 0.01 | 0.02 | - | - | - |
Total Current Liabilities | 0.03 | 0.03 | 0.04 | 0.01 | 0.17 | 0.03 |
Long-Term Debt | - | - | - | 0.01 | - | - |
Total Liabilities | 0.03 | 0.03 | 0.04 | 0.02 | 0.17 | 0.03 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2014 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '14 Dec 31, 2014 | Feb '14 Feb 28, 2014 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.07 |
Additional Paid-In Capital | 7.67 | 7.6 | 7.42 | 7.27 | 0.55 | 0.08 |
Retained Earnings | -7.64 | -7.55 | -7.4 | -7.15 | -0.87 | -0.19 |
Treasury Stock | - | - | - | -0.07 | - | - |
Comprehensive Income & Other | - | - | - | 0 | 1.81 | - |
Shareholders' Equity | 0.04 | 0.06 | 0.03 | 0.06 | 1.49 | -0.03 |
Total Liabilities & Equity | 0.08 | 0.09 | 0.07 | 0.08 | 1.66 | 0 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2014 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '14 Dec 31, 2014 | Feb '14 Feb 28, 2014 |
Total Debt | 0.02 | 0.02 | 0.02 | 0.01 | 0.09 | 0.02 |
Net Cash (Debt) | -0.01 | -0 | -0.02 | -0.01 | -0.01 | -0.02 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.07 |
Filing Date Shares Outstanding | 59.72 | 58.71 | 57.33 | 50.53 | 21.35 | 2.5 |
Total Common Shares Outstanding | 59.72 | 58.84 | 53.44 | 50.53 | 19.51 | 2.5 |
Working Capital | -0.03 | -0.02 | -0.04 | -0.01 | 0.88 | -0.03 |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | -0.01 |
Tangible Book Value | -0.03 | -0.01 | -0.04 | -0.02 | 1.49 | -0.03 |
Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | 0.08 | -0.01 |